ReviewJournal, genetic engineering & biotechnology2022

Multiplexed shRNA-miRs as a candidate for anti HIV-1 therapy: strategies, challenges, and future potential.

Jyotsna Jai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.